Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Conference News ACC 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

L.A. McKeown

March 17, 2017

News Daily News

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Caitlin E. Cox

October 18, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Conference News EAS 2016

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

Yael L. Maxwell

June 07, 2016

News Conference News EAS 2016

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

Yael L. Maxwell

June 06, 2016

News Daily News

ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors

Michael O'Riordan

April 02, 2016

News Daily News

Femoral Ultrasound Shows Promise for Atherosclerosis Screening, Risk Assessment

L.A. McKeown

March 15, 2016

News Daily News

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Michael O'Riordan

March 07, 2016

News Daily News

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

Michael O'Riordan

March 01, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Daily News

Meta-analysis Supports CTA’s Predictive Value

Caitlin E. Cox

June 08, 2011

Advertisement

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

August 2022 News Roundup

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

People Living in Amazon Rainforest Provide Clues to Coronary Protection

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors

Femoral Ultrasound Shows Promise for Atherosclerosis Screening, Risk Assessment

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Meta-analysis Supports CTA’s Predictive Value

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content